1. Home
  2. GSIW vs HBIO Comparison

GSIW vs HBIO Comparison

Compare GSIW & HBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GSIW

Garden Stage Limited

HOLD

Current Price

$0.13

Market Cap

28.6M

Sector

N/A

ML Signal

HOLD

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$0.73

Market Cap

33.8M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSIW
HBIO
Founded
2016
1901
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
33.8M
IPO Year
2023
2000

Fundamental Metrics

Financial Performance
Metric
GSIW
HBIO
Price
$0.13
$0.73
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
$2.50
AVG Volume (30 Days)
299.7K
682.2K
Earning Date
01-01-0001
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,368,221.00
$87,371,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.22
P/E Ratio
N/A
N/A
Revenue Growth
283.23
N/A
52 Week Low
$0.09
$0.28
52 Week High
$1.79
$2.28

Technical Indicators

Market Signals
Indicator
GSIW
HBIO
Relative Strength Index (RSI) 39.19 53.17
Support Level $0.13 $0.71
Resistance Level $0.14 $0.80
Average True Range (ATR) 0.01 0.06
MACD -0.00 -0.01
Stochastic Oscillator 12.65 28.35

Price Performance

Historical Comparison
GSIW
HBIO

About GSIW Garden Stage Limited

Garden Stage Ltd is a Hong Kong-based financial services provider principally engaged in the provision of placing and underwriting services; securities dealing and brokerage services; and asset management services. Its business is carried out through its wholly owned Operating Subsidiaries: I Win Securities, which is licensed to conduct Type 1 (dealing in securities) regulated activities under the SFO in Hong Kong; and I Win Asset Management, which is licensed to conduct Type 4 (advising on securities) and Type 9 (asset management) regulated activities under the SFO in Hong Kong.

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

Share on Social Networks: